18,000 Shares in GP-Act III Acquisition Corp. (NASDAQ:GPAT) Purchased by Wellspring Financial Advisors LLC

Wellspring Financial Advisors LLC purchased a new stake in GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 18,000 shares of the company’s stock, valued at approximately $183,000.

Other large investors have also recently modified their holdings of the company. Wolverine Asset Management LLC increased its position in shares of GP-Act III Acquisition by 4.0% in the fourth quarter. Wolverine Asset Management LLC now owns 298,553 shares of the company’s stock worth $3,027,000 after purchasing an additional 11,439 shares during the last quarter. Tidal Investments LLC purchased a new position in GP-Act III Acquisition in the 3rd quarter worth approximately $307,000. Finally, Rivernorth Capital Management LLC bought a new position in shares of GP-Act III Acquisition in the 3rd quarter worth $4,548,000.

GP-Act III Acquisition Stock Up 0.2 %

NASDAQ GPAT opened at $10.32 on Monday. GP-Act III Acquisition Corp. has a 52-week low of $9.98 and a 52-week high of $10.32. The company has a fifty day moving average of $10.28 and a 200-day moving average of $10.17.

GP-Act III Acquisition Profile

(Free Report)

GP-Act III Acquisition Corp. operates as a blank check company, which was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 23, 2020 and is headquartered in New York, NY.

Featured Stories

Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report).

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.